How inflammation affects JAK2‑mutant blood cells
Official title: Effect of inflammation on JAK2 mutant evolution in the hematopoietic system: mathematical models and experiments
Funded at University of California-Irvine · NIH-11473217 · Data updated 2026-11-12
This project looks at whether inflammation helps JAK2‑mutant blood cells grow in people with early myeloproliferative neoplasms and could point to ways to slow disease progression.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project start | May 30, 2022 |
| Project end | March 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $87,317 |
| NIH project number | 3R37CA271172-05S1 |
| Project ID | NIH-11473217 on NIH RePORTER |
Who could benefit from this research
✓Could help
People with early-stage myeloproliferative neoplasms who carry the JAK2V617F mutation would be the most relevant group for this research.
✕Less likely to help
People without JAK2 mutations or those with advanced myelofibrosis or established acute leukemia are less likely to benefit directly from this project.
What this research studies
I want to know whether inflammation changes how blood cells carrying the JAK2 mutation expand and compete with normal cells. The team will combine laboratory experiments on cells and biological models with mathematical modeling to track mutant versus wild-type cell behavior. Their goal is to see if altering inflammation can shift the evolutionary fate of JAK2‑mutant cells and delay progression to myelofibrosis or acute leukemia. This is primarily lab and modeling work that could guide future patient-focused therapies but is not itself a clinical treatment trial.
Why it matters
Potential benefit: If successful, this work could lead to new ways to slow or prevent progression of early MPN and reduce the risk of myelofibrosis or AML.
How similar studies have gone: Preliminary lab and modeling data indicate inflammation can favor JAK2‑mutant cell growth, but using that insight to alter disease progression is a novel and unproven approach.
Where this research is happening
-
University of California-Irvine
Irvine, United States Active
Researchers
- Principal investigator: Fleischman, Angela Goffredo — University of California-Irvine
- Study coordinator: Fleischman, Angela Goffredo
Related research
Other NIH-funded projects on the same topics.
-
Retinal cell grafts to restore sight in AMD and RP
A patient-focused program aims to replace damaged retinal cells with organized, transplant-ready sheets created from stem cells to improve vision in age-related macular degeneration and related diseases.
-
Treg-based tolerance to dystrophin immune responses in Duchenne muscular dystrophy
A new grant aims to help people with Duchenne muscular dystrophy by teaching the immune system to tolerate the dystrophin treatment delivered by gene therapy.
-
Immune and NGF factors in Alzheimer’s for adults with Down syndrome
This grant studies why people with Down syndrome develop Alzheimer’s disease by looking at immune signals and nerve growth factor problems.
-
Promoting Heart Cell Maturation with Light-Activated Engineered Peptides
Aims to help grown heart cells from stem cells mature more like real adult heart tissue using special peptide coatings that respond to light.
-
Understanding how heart nerves affect dangerous heart rhythms after a heart attack
This NIH grant studies how changes in the heart’s nerve signaling after a heart attack lead to dangerous rhythm problems, with the goal of finding ways to prevent them.
-
All of Us Southern California Consortium supports broad participation in a national health data program
A national health data program in Southern California works to recruit and retain adults to share health information and participate in research that uses this data.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.